An efficient process is disclosed for producing a compound that is an inhibitor of CETP. The last step of the process is the coupling of an oxazolidinone derivative with a biphenyl moiety to provide a compound of formula (I). In a specific embodiment of this synthesis, a crystalline product is produced which is characterized as a non-solvated crystalline polymorph.

 
Web www.patentalert.com

< ELECTRICAL STIMULATION SYSTEM AND METHOD FOR STIMULATING TISSUE IN THE BRAIN TO TREAT A NEUROLOGICAL CONDITION

> THERAPEUTIC AGENT FOR DIABETIC NEUROPATHY

> COMPOSITION AND METHOD OF ADIPOSE CELL DIFFERENTIATION INHIBITION

~ 00579